Investigation of inclusion complex of Cilnidipine (cas 132203-70-4) with hydroxypropyl-β-cyclodextrin
-
Add time:08/02/2019 Source:sciencedirect.com
The objective of this study was to improve the water-solubility and photostability of Cilnidipine (cas 132203-70-4) by complexing it with hydroxypropyl-β-cyclodextrin (HP-β-CD or HP-beta-CD). The interactions of cilnidipine and HP-β-CD were characterized by ultra violet–visible (UV/VIS) spectroscopy, differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), Fourier transformation-infrared (FT-IR) spectroscopy and 1H nuclear magnetic resonance (1H NMR) spectroscopy to verify the formation of cilnidipine-HP-β-CD complex inclusion. Moreover, the binding sites in the HP-β-CD structure were also tracked through 1H NMR spectroscopy analysis. All the characterization information proved the formation of cilnidipine-HP-β-CD inclusion complex, and the results demonstrated the superiority of the inclusion complex in dissolution rates and photostability; in addition, the apparent solubility of cilnidipine was increased more than 10,000-fold in the presence of HP-β-CD. The stability constant (1:1) was found to be 50,116 M−1, suggesting a high tendency of the drug to enter the HP-β-CD cavity. These results identified the cilnidipine-HP-β-CD inclusion complex as an effective new approach to design a novel formulation for pharmaceutical application.
We also recommend Trading Suppliers and Manufacturers of Cilnidipine (cas 132203-70-4). Pls Click Website Link as below: cas 132203-70-4 suppliers
Prev:N- and L-type calcium channels blocker Cilnidipine (cas 132203-70-4) ameliorates neuropathic pain
Next:Role of P-Glycoprotein in Regulating Cilnidipine (cas 132203-70-4) Distribution to Intact and Ischemic Brain) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Effects of Cilnidipine (cas 132203-70-4) on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: Association with BNP and aldosterone levels08/06/2019
- Antialbuminuric advantage of Cilnidipine (cas 132203-70-4) compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria08/05/2019
- Anti-stress effects of Cilnidipine (cas 132203-70-4) and nimodipine in immobilization subjected mice08/04/2019
- Role of P-Glycoprotein in Regulating Cilnidipine (cas 132203-70-4) Distribution to Intact and Ischemic Brain08/03/2019
- N- and L-type calcium channels blocker Cilnidipine (cas 132203-70-4) ameliorates neuropathic pain08/01/2019


